Globe Life (NYSE:GL) CEO Frank Svoboda Sells 9,379 Shares

by · The Cerbat Gem

Globe Life Inc. (NYSE:GL – Get Free Report) CEO Frank Svoboda sold 9,379 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the transaction, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,036,943.24. The trade was a 20.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Globe Life Stock Down 0.4%

GL stock opened at $138.16 on Thursday. Globe Life Inc. has a twelve month low of $104.06 and a twelve month high of $147.83. The stock has a 50-day simple moving average of $134.13 and a two-hundred day simple moving average of $132.93. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $11.00 billion, a PE ratio of 10.02 and a beta of 0.48.

Globe Life (NYSE:GL – Get Free Report) last announced its earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.54 by $0.27. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. The company had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same period in the previous year, the business earned $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. On average, equities analysts predict that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Monday, January 5th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, January 5th. Globe Life’s dividend payout ratio (DPR) is presently 7.83%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in GL. AdvisorNet Financial Inc grew its holdings in shares of Globe Life by 60.0% during the 2nd quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 84 shares during the period. Intech Investment Management LLC lifted its stake in shares of Globe Life by 0.8% in the second quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock worth $1,438,000 after acquiring an additional 95 shares in the last quarter. CX Institutional boosted its stake in shares of Globe Life by 5.6% during the 3rd quarter. CX Institutional now owns 1,805 shares of the company’s stock valued at $258,000 after buying an additional 96 shares during the last quarter. Laird Norton Wetherby Wealth Management LLC boosted its stake in Globe Life by 2.2% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after acquiring an additional 99 shares during the last quarter. Finally, KLP Kapitalforvaltning AS grew its stake in Globe Life by 0.5% in the third quarter. KLP Kapitalforvaltning AS now owns 22,000 shares of the company’s stock worth $3,145,000 after purchasing an additional 100 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Morgan Stanley reaffirmed an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a research report on Monday. Keefe, Bruyette & Woods increased their price target on Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a report on Tuesday, October 28th. Truist Financial raised their price objective on shares of Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a report on Friday, October 24th. Wells Fargo & Company lowered their target price on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Globe Life in a report on Monday. Nine equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and an average target price of $164.89.

Read Our Latest Research Report on GL

Globe Life Company Profile

(Get Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Read More